A gene on the X chromosome revs up inflammation in the female brain, which may explain why rates of multiple sclerosis are ...

Zenas Biopharma’s lead autoimmune drug has been tied to a 95% reduction in a type of brain lesions over 12 weeks in a phase 2 multiple sclerosis (MS) study.  | Zenas Biopharma’s lead autoimmune drug ...

Multiple sclerosis and Alzheimer's disease each affect women more often than men, about two to three times as often, ...

An X chromosome gene appears to drive inflammation in the brain, and may explain why women are more likely to develop MS, per ...

Researchers have identified a gene on the X chromosome that drives inflammation in the female brain and explains the reason ...

MOG-IgG positivity is rare in MS patients, complicating diagnosis and treatment, especially in Asian populations with lower ...

Being diagnosed with multiple sclerosis can often be an isolating experience, and even more so for those in Darwin who lack ...